CAPR Capricor Therapeutics, Inc.
Healthcare$28.87-2.40%ClosedMarket Cap: $1.32B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$50.88
Target (Median)
$50.00
Target Range
$38.00 - $62.00
Upside from current price: 76.2%
Rating Distribution
2 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-13 | B. Riley Securities | maintain | Buy | Buy |
| 2026-03-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-13 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-12-15 | B. Riley Securities | maintain | Buy | Buy |
| 2025-12-10 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-12-08 | Oppenheimer | maintain | Outperform | Outperform |
| 2025-12-04 | Maxim Group | maintain | Buy | Buy |
| 2025-12-03 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-12 | Roth Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.69 | $104.5M | 7 |
| Sun Dec 31 | $1.62 | $245.5M | 4 |
| Mon Dec 31 | $3.84 | $399.8M | 2 |
| Tue Dec 31 | $6.60 | $623.2M | 2 |